1. RSK2 and its binding partners in cell proliferation, transformation and cancer development

   • Yong-Yeon Cho

   Review 24 December 2016 Pages: 291 - 303

   

2. Cinnamomulactone, a new butyrolactone from the twigs of Cinnamomum cassia and its inhibitory activity of matrix metalloproteinases

   • Geum Jin Kim
   • Jong Yeong Lee
   • Hyukjae Choi

   Research Article 28 December 2016 Pages: 304 - 310

   

3. A new saponin from Acanthopanax koreanum with anti-inflammatory activity

   • Le Duc Dat
   • Nguyen Phuong Thao
   • Young Ho Kim

   Research Article 29 December 2016 Pages: 311 - 317

   

4. Oleanane triterpenoids from Akebiae Caulis exhibit inhibitory effects on Aβ42 induced fibrillogenesis

   • Md. Anisuzzaman Chowdhury
   • Hae Ju Ko
   • Eun-Rhan Woo

   Research Article 04 January 2017 Pages: 318 - 327

   

5. Anti-inflammatory effects of secondary metabolites isolated from the marine-derived fungal strain Penicillium sp. SF-5629

   • Nguyen Thi Thanh Ngan
   • Tran Hong Quang
   • Hyuncheol Oh

   Research Article 10 January 2017 Pages: 328 - 337

   

6. Anti-Alzheimer’s disease activity of compounds from the root bark of Morus alba L.

   • Eun Bi Kuk
   • A. Ra Jo
   • Hyun Ah Jung

   Research Article 16 January 2017 Pages: 338 - 349

   

7. Liquid chromatographic enantiomer separation of 1-naphthylamides of chiral acids using several amylose- and cellulose-derived chiral stationary phases

   • Md. F. Islam
   • Suraj Adhikari
   • Wonjae Lee

   Research Article 10 January 2017 Pages: 350 - 355

   

8. Chitosan–ceramide coating on gold nanorod to improve its physiological stability and reduce the lipid surface-related toxicity

   • Gantumur Battogtokh
   • Oyuntuya Gotov
   • Young Tag Ko

   Research Article 11 January 2017 Pages: 356 - 363

   

9. Determination of urazamide in pharmaceutical preparation with room temperature ionic liquid

   • Narae Seo
   • Yoo Rim Lee
   • Kyeong Ho Kim

   Research Article 15 February 2017 Pages: 364 - 372

   

10. Determination of rabeprazole enantiomers in commercial tablets using immobilized cellulose-based stationary phase

    • Miri Kim
    • Su Kyung Yu
    • Kyeong Ho Kim

    Research Article 22 February 2017 Pages: 373 - 381

    

11. Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite

    • Se-Hyung Kim
    • Do-Hoon Kim
    • Seok-Yong Lee

    Research Article 18 November 2016 Pages: 382 - 390

    

12. Amelioration of high fat diet-induced nephropathy by cilostazol and rosuvastatin

    • Jeong-hyeon Park
    • Bo-hyun Choi
    • Mi-Kyoung Kwak

    Research Article 13 January 2017 Pages: 391 - 402